Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LINK IT TWO: EPA and Rosuvastatin for Neoatherosclerosis
NCT03657758Phase 4Unknown
- Sponsor
- Kobe University
- Start
- Sep 2018
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of eicosapentaenoic acid in coronary artery disease (CAD), sponsored by Kobe University. Status: unknown.
02
Drugs
eicosapentaenoic acid
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03657758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03657758.